-
FDA approves Verzenio for metastatic breast cancer
europeanpharmaceuticalreview
September 30, 2017
The FDA has approved Verzenio to treat advanced or metastatic breast cancer that has progressed after taking therapy…
-
NICE turns down AZ’ Faslodex for breast cancer
pharmatimes
September 04, 2017
It is looking unlikely that AstraZeneca’s breast cancer drug Faslodex will be routinely funded on the NHS to delay growth of a specific type of breast cancer, after cost regulators concluded that its benefit over existing therapies has not been shown at t
-
Z-endoxifen to become a new treatment of breast cancer
europeanpharmaceuticalreview
September 01, 2017
Z-endoxifen could itself be a new treatment for the most common form of breast cancer.
-
FDA approves AstraZeneca’s faslodex for expanded use in breast cancer
pharmaceutical-technology
August 31, 2017
AstraZeneca’s faslodex (fulvestrant) at 500mg has received approval from the US Food and Drug Administration (FDA) as monotherapy for expanded use in women with advanced breast cancer.
-
AstraZeneca oldie Faslodex nets another breast cancer approval
fiercepharma
August 30, 2017
AstraZeneca's Faslodex won its first approval back in 2002.
-
FDA Grants Breakthrough Therapy Designation to DS-8201
americanpharmaceuticalreview
August 30, 2017
FDA has granted Breakthrough Therapy designation to DS-8201, an investigational HER2-targeting antibody drug conjugate (ADC), for the treatment of patients with HER2-positive
-
EC approves Novartis’ breast cancer drug Kisqali
expressbpd
August 28, 2017
Swiss drugmaker Novartis’ Kisqali (ribociclib) has received approval from the European Commission (EC) as a first-line treatment for advanced breast cancer.
-
Can Novartis' Kisqali beat Pfizer's market-leading Ibrance to reimbursement in England?
fiercepharma
August 25, 2017
The Swiss drugmaker’s breast cancer drug won a European green light for use in tandem with any aromatase inhibitor.
-
New molecule may foresee the spread of breast cancer
europeanpharmaceuticalreview
August 17, 2017
Researchers have developed a new imaging technique to detect myeloid-derived suppressor cells’ accumulating in the lung…
-
Biocon withdraws application for EU approval of two drugs
expressbpd
August 17, 2017
EU drugs regulator sought re-inspection of their production facility